Peptides

Peptide therapeutics are critical therapeutics for a range of pathologies. Their recent uptake as a treatment for obesity has seen...

Peptide injectable development can bring complex formulation challenges, especially in diabetes and obesity where GLP-1 therapeutics need to maintain stability,...

Abstract Oral delivery of peptides represents a promising alternative to invasive injectable therapies, offering improved patient adherence and convenience. Glucagon-like...

Abstract Contemporary small-molecule drug candidates increasingly have limited aqueous solubility, rendering oral delivery challenging. Amorphous solid dispersions (ASDs) and lipid-based...

See our next Live Webinar on the topic of: Lipid-based formulations and enteric capsules to enhance oral bioavailability of peptides...

Abstract Introduction Therapeutic proteins are crucial in the treatment of a wide range of diseases. However, the proteins are sensitive...

Oral delivery, by Gattefossé, remains the most patient friendly route of administration. Yet for peptides, it has long been considered...

Abstract Polymer nanoparticles (PNPs) are compact particulate systems typically ranging from 10 to 1000 nm in size and have emerged...

Abstract Introduction This study explores the emulsification behavior and oral delivery performance of dry and wet inverted lipid phases (ILPdry and...

Abstract Biopharmaceutical medicines represent one of the most dynamic sectors of the pharmaceutical industry, with therapeutic proteins forming the largest...